Cargando…
T Cell Epitope Peptide Therapy for Allergic Diseases
Careful selection of dominant T cell epitope peptides of major allergens that display degeneracy for binding to a wide array of MHC class II molecules allows induction of clinical and immunological tolerance to allergen in a refined treatment strategy. From the original concept of peptide-induced T...
Autores principales: | O’Hehir, Robyn E., Prickett, Sara R., Rolland, Jennifer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713452/ https://www.ncbi.nlm.nih.gov/pubmed/26768622 http://dx.doi.org/10.1007/s11882-015-0587-0 |
Ejemplares similares
-
Cross-Reactivity of Peanut Allergens
por: Bublin, Merima, et al.
Publicado: (2014) -
Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy
por: Blank, Simon, et al.
Publicado: (2020) -
Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1)
por: Goretzki, A., et al.
Publicado: (2022) -
Defining Pollen Seasons: Background and Recommendations
por: Bastl, Katharina, et al.
Publicado: (2018) -
Update on House Dust Mite Allergen Avoidance Measures for Asthma
por: Zuiani, Chiara, et al.
Publicado: (2020)